SGLT2 Inhibition in HFpEF. Do We Need More Quantitative and Load Independent Metrics to Understand the Results of the EMPEROR-Preserved Trial?

Overview of attention for article published in Frontiers in Cardiovascular Medicine, January 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 4 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 3,688 followers.

Latest publications from our PIs: EMPEROR-Preserved Trial "SGLT2 Inhibition in HFpEF. Do We Need More Quantitative and Load Independent Metrics to Understand the Results of the EMPEROR-Preserved Trial?" https://t.co/WTVOzD2qhJ

09 Mar 2022

Reply Repost Favourite

RT @SKelle_Berlin: SGLT2 Inhibition in HFpEF. Do We Need More Quantitative and Load Independent Metrics to Understand the Results of the EM…

27 Jan 2022

Reply Repost Favourite

SGLT2 Inhibition in HFpEF. Do We Need More Quantitative and Load Independent Metrics to Understand the Results of the EMPEROR-Preserved Trial? https://t.co/ZmeLZjYmun

16 Jan 2022

Reply Repost Favourite

RT @FrontCVMedicine: New Research: SGLT2 Inhibition in HFpEF. Do We Need More Quantitative and Load Independent Metrics to Understand the R…

15 Jan 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.